title: Desmopressin may be hazardous in thrombotic microangiopathy.
authors.affiliation: Lister Hospital, Stevenage, UK.
authors.forename: J
authors.initials: J
authors.lastname: Stratton
authors.forename: P
authors.initials: P
authors.lastname: Warwicker
authors.forename: S
authors.initials: S
authors.lastname: Watkins
authors.forename: K
authors.initials: K
authors.lastname: Farrington
mesh_terms: D000743:Anemia, Hemolytic / Q000188:drug therapy* / Q000209:etiology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D003894:Deamino Arginine Vasopressin / Q000009:adverse effects*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology; D006490:Hemostatics / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D013927:Thrombosis / Q000188:drug therapy*
chemical_list: D006490:Hemostatics; D003894:Deamino Arginine Vasopressin